Essayer OR - Gratuit
LIGHT, MIGRAINE BEYOND PAIN UNDERSTANDING SMELL, AND HORMONAL TRIGGERS IN URBAN PATIENTS
Healthcare Radius
|July 2025
As our scientific understanding of migraine continues to deepen and as technology enables the development of increasingly personalized interventions, there is a growing potential to fundamentally transform the lived experience of migraine patients

Migraines represent a significant global health challenge, affecting an estimated one billion individuals worldwide. For healthcare providers and the medical technology sector, this neurological disorder presents not only a substantial clinical challenge but also a continuously expanding market opportunity. This is particularly pronounced in urban environments, characterized by their inherent heightened sensory stimuli, often demanding lifestyle stressors, and varying levels of pollution, all of which can markedly increase both the prevalence and the perceived severity of migraine episodes. Patients navigating urban life frequently experience migraines triggered by a confluence of factors, including heightened sensitivity to light (photophobia), an acute sensitivity to odors (osmophobia), and, notably in women, the often-predictable yet disruptive influence of hormonal fluctuations.
While the primary characteristic of migraines is often perceived to be the presence of debilitating headaches, the complete spectrum of this intricate neurological disorder extends considerably beyond this singular symptom. Migraines involve a complex interplay of vascular, neurological, hormonal, and environmental factors that can manifest in a diverse array of symptoms, frequently triggered by seemingly ordinary stimuli. Among urban patients, where the pressures of lifestyle and the intensity of environmental stressors are uniquely compounded, a deep understanding of these nuanced triggers becomes even more critical for accurate diagnosis and the implementation of truly effective treatment strategies. Of these often-underestimated triggers, photophobia (sensitivity to light), osmophobia (sensitivity to smells), and hormonal fluctuations are particularly significant, yet often remain under-discussed in routine clinical practice.
Cette histoire est tirée de l'édition July 2025 de Healthcare Radius.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Healthcare Radius

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Listen
Translate
Change font size